 |
PDBsum entry 3qqu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qqu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Discovery of 2,4-Bis-Arylamino-1,3-Pyrimidines as insulin-Like growth factor-1 receptor (igf-1r) inhibitors.
|
|
|
Authors
|
|
J.L.Buchanan,
J.R.Newcomb,
D.P.Carney,
S.C.Chaffee,
L.Chai,
R.Cupples,
L.F.Epstein,
P.Gallant,
Y.Gu,
J.C.Harmange,
K.Hodge,
B.E.Houk,
X.Huang,
J.Jona,
S.Joseph,
H.T.Jun,
R.Kumar,
C.Li,
J.Lu,
T.Menges,
M.J.Morrison,
P.M.Novak,
S.Van der plas,
R.Radinsky,
P.E.Rose,
S.Sawant,
J.R.Sun,
S.Surapaneni,
S.M.Turci,
K.Xu,
E.Yanez,
H.Zhao,
X.Zhu.
|
|
|
Ref.
|
|
Bioorg Med Chem Lett, 2011,
21,
2394-2399.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
